Upstaging to pT3a disease in patients undergoing robotic partial nephrectomy for cT1 kidney cancer: Outcomes and predictors from a multi-institutional dataset.

Journal: Urologic oncology
Published Date:

Abstract

OBJECTIVES: Surgically treated clinical T1 (cT1) kidney cancer has in general a good prognosis, but there is a risk of upstaging that can potentially jeopardize the oncological outcomes after partial nephrectomy (PN). Aim of this study is to analyze the outcomes of robot-assisted PN (RAPN) for cT1 kidney cancer upstaged to pT3a, and to identify predictors of upstaging.

Authors

  • Alessandro Veccia
    Department of Urology, Azienda Ospedaliera Universitaria Integrata Verona, Verona, Italy.
  • Alessandro Antonelli
    Department of Urology, Azienda Ospedaliera Universitaria Integrata Verona, University of Verona, Verona, Italy.
  • Andrea Minervini
    Department of Urology, Careggi Hospital, University of Florence, Florence, Italy.
  • Alexandre Mottrie
    ORSI Academy Melle Belgium.
  • Paolo Dell'Oglio
    Division of Oncology/Unit of Urology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy; Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada.
  • Akbar N Ashrafi
    USC Institute of Urology, Catherine and Joseph Aresty Department of Urology, Keck School of Medicine, University of Southern California, Los Angeles, CA.
  • Alessandro Larcher
    Division of Oncology, Unit of Urology, IRCCS Ospedale San Raffaele, Milan, Italy.
  • Daniel Eun
    Department of Urology, Lewis Katz School of Medicine at Temple University, Philadelphia, PA.
  • Aaron Bradshaw
    Department of Urology, UC San Diego Health System, La Jolla, CA.
  • Daniele Amparore
    Division of Urology, Department of Oncology, University of Turin, San Luigi Gonzaga Hospital, Orbassano, Turin, Italy.
  • Aldo Brassetti
    Fondazione Vincenzo Pansadoro, Centro di Urologia Laparoscopica e Oncologia Medica, Rome, Italy. Electronic address: aldo.brassetti@gmail.com.
  • Lance J Hampton
    Division of Urology, Department of Surgery, VCU Health System, Richmond, VA.
  • Claudio Simeone
    Urology Unit, ASST Spedali Civili Hospital, Department of Medical and Surgical Specialties, Radiological Science, and Public Health, University of Brescia , Italy.
  • Andrea Mari
  • Marco Carini
  • Geert De Naeyer
    General Surgery and Urology. OLV Hospital. Belgium.
  • Kevin Yang
    Computer Science and Artificial Intelligence Laboratory , MIT , Cambridge , Massachusetts 02139 , United States.
  • Umberto Capitanio
    Unit of Urology, Division of Experimental Oncology, Urological Research Institute (URI), IRCCS Ospedale San Raffaele, Milan, Italy.
  • Giuseppe Simone
    Department of Urology, Regina Elena National Cancer Institute, Rome, Italy.
  • Francesco Porpiglia
    Division of Urology, Department of Oncology, University of Turin, San Luigi Gonzaga Hospital, Orbassano, Turin, Italy.
  • Ithaar Derweesh
    Department of Urology, UC San Diego Health System, La Jolla, CA.
  • Monish Aron
    USC Institute of Urology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA. Electronic address: monisharon@hotmail.com.
  • Riccardo Autorino
    Department of Urology, Rush University, Chicago, IL, USA.